Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Equity Ratio (2016 - 2025)

Historic Equity Ratio for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to 0.88.

  • iBio's Equity Ratio rose 3715.51% to 0.88 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.88, marking a year-over-year increase of 3715.51%. This contributed to the annual value of 0.64 for FY2025, which is 1351.85% down from last year.
  • Latest data reveals that iBio reported Equity Ratio of 0.88 as of Q4 2025, which was up 3715.51% from 0.87 recorded in Q3 2025.
  • Over the past 5 years, iBio's Equity Ratio peaked at 0.88 during Q4 2025, and registered a low of 0.27 during Q4 2023.
  • In the last 5 years, iBio's Equity Ratio had a median value of 0.64 in 2024 and averaged 0.61.
  • Per our database at Business Quant, iBio's Equity Ratio surged by 68383.19% in 2021 and then tumbled by 4928.31% in 2022.
  • Quarter analysis of 5 years shows iBio's Equity Ratio stood at 0.72 in 2021, then plummeted by 49.28% to 0.36 in 2022, then dropped by 25.61% to 0.27 in 2023, then soared by 136.9% to 0.64 in 2024, then skyrocketed by 37.16% to 0.88 in 2025.
  • Its Equity Ratio stands at 0.88 for Q4 2025, versus 0.87 for Q3 2025 and 0.64 for Q2 2025.